Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 10:28 am Purchase | 2025-10-31 | 13G | MGP Ingredients, Inc. MGPI | FEDERATED HERMES INC. FHI | 1,101,767 5.170% | 1,101,767 (New Position) | Filing History |
| 2025-10-28 4:39 pm Unchanged | 2025-10-21 | 13D | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,351,275 19.320% | 0 (Unchanged) | Filing History |
| 2025-10-07 11:14 am Sale | 2025-09-30 | 13G | SoundThinking, Inc. SSTI | FEDERATED HERMES INC. FHI | 1,000,000 7.820% | -315,000 (-23.95%) | Filing History |
| 2025-10-07 11:11 am Sale | 2025-09-30 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 5,116,598 11.260% | -1,311,652 (-20.40%) | Filing History |
| 2025-10-07 11:08 am Purchase | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,635,380 13.150% | 156,733 (+10.60%) | Filing History |
| 2025-10-07 11:03 am Sale | 2025-09-30 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 10,544,437 10.760% | -4,122,163 (-28.11%) | Filing History |
| 2025-09-05 09:38 am Purchase | 2025-08-31 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,478,647 11.890% | 406,414 (+37.90%) | Filing History |
| 2025-07-08 07:50 am Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,072,233 8.780% | 1,072,233 (New Position) | Filing History |
| 2025-07-08 07:30 am Purchase | 2025-06-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FEDERATED HERMES INC. FHI | 4,599,450 6.680% | 892,086 (+24.06%) | Filing History |
| 2025-06-04 09:19 am Sale | 2025-05-31 | 13G | Virgin Galactic Holdings, Inc. SPCE | FEDERATED HERMES INC. FHI | 209,985 0.510% | -1,746,214 (-89.27%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 5,219,607 6.400% | -3,339,600 (-39.02%) | Filing History |
| 2025-04-07 10:44 am Purchase | 2025-03-31 | 13G | Virgin Galactic Holdings, Inc. SPCE | FEDERATED HERMES INC. FHI | 1,956,199 5.510% | 1,956,199 (New Position) | Filing History |
| 2025-01-08 1:46 pm Sale | 2024-12-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 6,428,250 15.500% | -700,000 (-9.82%) | Filing History |
| 2025-01-08 1:38 pm Unchanged | 2024-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 17.470% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:56 am Unchanged | 2024-10-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 7,128,250 17.220% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:54 am Purchase | 2024-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FEDERATED HERMES INC. FHI | 3,707,364 5.440% | 3,707,364 (New Position) | Filing History |
| 2024-10-07 1:38 pm Sale | 2024-09-30 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 7,128,250 18.830% | -966,450 (-11.94%) | Filing History |
| 2024-10-07 1:36 pm Purchase | 2024-09-30 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 19.350% | 4,497,000 (+44.22%) | Filing History |
| 2024-10-07 1:33 pm Purchase | 2024-09-30 | 13G | Smith Douglas Homes Corp. SDHC | FEDERATED HERMES INC. FHI | 527,300 5.960% | 527,300 (New Position) | Filing History |
| 2024-09-09 11:31 am Sale | 2024-08-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 6,158,200 4.700% | -5,206,466 (-45.81%) | Filing History |